CTXR Citius Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$0.53
· of 52w range
· above low
· to high
$0.4752w low
$2.1952w high
Market Cap (MRQ)
$15M
P/E
-0.4
EPS
$-3.38
your badges
52W Range
$0–$2
Analyst Rating
BUY
Price Target
$4
P/E
-0.4
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
CTXR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.53
Market Cap (MRQ)
$15M
P/E
-0.4
EPS
$-3.38
52W Range
$0–$2
CTXR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Nov. 26, 2024 | 1-for-25 | Reverse |
| June 9, 2017 | 1-for-15 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-3.382021-09-30 → 2025-09-30
Free Cash Flow·2020-09-30 → 2021-09-30
Net margin·2016-09-30 → 2016-09-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CTXR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.45Y avg ≈-71.5 | ≈-71.5 | · | · | |
| P/B (MRQ) | 0.25Y avg ≈43.0 | ≈43.0 | 1.5 | Undervalued | |
| Price / Tangible Book | 0.45Y avg ≈28.6 | ≈28.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CTXR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.85Y avg ≈11.4 | ≈11.4 | 4.4 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-106.0%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2025 | $-0.72 | $-0.50 | -45.0% | |
| June 30, 2025 | $-0.80 | $-0.60 | -32.9% | |
| March 31, 2025 | $-1.27 | $-0.39 | -224.8% | |
| Dec. 31, 2024 | $-1.30 | $-0.59 | -121.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | · | · | · | · | · | · | · | $75.0K | $50.0K | $45.0K | · | · | |
| R&D Expense | $9M | $12M | $15M | $18M | $12M | $9M | $9M | $7M | $3M | $3M | $2M | $574 | |
| SG&A Expense | $19M | $18M | $15M | $12M | $10M | $8M | $6M | $6M | $6M | $4M | $946.6K | $183.0K | |
| Operating Expenses | $39M | $42M | $37M | $33M | $24M | $18M | $16M | $14M | $10M | $7M | $3M | $653.8K | |
| Operating Income | $-39M | $-42M | $-37M | $-33M | $-24M | $-18M | $-16M | $-14M | $-10M | $-7M | $-3M | $-653.8K | |
| Interest Expense | · | · | · | · | $10.8K | $15.7K | $16.4K | $15.8K | $850.8K | $9.0K | $7.5K | $93.1K | |
| Interest Income | $110.1K | $758.0K | $1M | $251.4K | $261.8K | $68.1K | $52.7K | · | · | $806 | · | · | |
| Other Non-op | $-157.7K | $3M | $5M | $251.4K | $477.5K | $162.6K | $36.2K | $1M | $-398.6K | $-846.4K | $348.0K | · | |
| Pretax Income | $-39M | $-39M | $-32M | $-33M | $-23M | $-18M | $-16M | $13M | $10M | $-8M | $-3M | $-737.7K | |
| Income Tax | $1M | $576.0K | $576.0K | $576.0K | $1.2K | $741 | · | · | · | · | · | · | |
| Net Income | $-40M | $-39M | $-33M | $-34M | $-23M | $-18M | $-16M | $-13M | $-10M | $-8M | $-3M | $-737.7K | |
| EPS (Basic) | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 | · | · | · | · | · | · | · | |
| Shares (Basic) | 11,065,225 | 6,726,999 | 6,051,789 | 146,082,399 | 108,599,080 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 11,065,225 | 6,726,999 | 6,051,789 | 146,082,399 | 108,599,080 | · | · | · | · | · | · | · | |
| EBITDA | · | · | $-37M | $-33M | $-24M | $-18M | $-16M | $-14M | · | $-7M | $-3M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $26M | $42M | $70M | $14M | $8M | $9M | $3M | $294.4K | $676.1K | $2M | |
| Inventory | $22M | $8M | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $3M | $8M | $3M | $3M | $122.2K | $48.1K | $57.7K | $220.2K | $598.5K | $60.0K | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $19M | · | · | |
| Current Assets | $28M | $14M | $34M | $45M | $73M | $14M | $8M | $10M | $3M | $892.8K | $736.1K | $2M | |
| PP&E (Net) | · | · | $1.4K | $4.1K | $7.0K | $1.6K | $590 | $1.5K | $3.2K | $3.7K | · | · | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | $8.5K | · | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | $4.8K | · | · | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $2M | $2M | $2M | · | · | |
| Other Non-current Assets | $102M | $102M | $69M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $131M | $117M | $104M | $114M | $142M | $44M | $37M | $31M | $24M | $22M | $741.5K | $2M | |
| Accounts Payable | $14M | $5M | $3M | $1M | $1M | $2M | $3M | $2M | $602.4K | $909.2K | $559.1K | $106.2K | |
| Accrued Liabilities | $4M | $17.0K | $476.3K | $1M | $622.0K | $164.0K | $246.2K | $181.7K | $560.9K | $958.1K | $8.3K | $60.3K | |
| Short-term Debt | $1M | · | · | · | · | $173.0K | $173.0K | $173.0K | $173.0K | $673.0K | · | · | |
| Current Liabilities | $45M | $36M | $6M | $5M | $4M | $4M | $5M | $3M | $2M | $5M | $1M | $2M | |
| Capital Leases | $724.9K | $21.3K | $262.9K | $481.2K | $678.2K | $855.5K | · | · | · | · | · | · | |
| Deferred Tax | $8M | $7M | $6M | $6M | $5M | $5M | $5M | · | · | · | · | · | |
| Total Liabilities | $53M | $43M | $12M | $11M | $10M | $10M | $10M | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | $173.0K | $173.0K | $173.0K | · | · | · | · | |
| Common Stock | $18.1K | $7.2K | $6.4K | $146.2K | $146.0K | $55.6K | $28.9K | $16.2K | $8.3K | $4.9K | $34.1K | $30.0K | |
| Paid-in Capital | $306M | $271M | $253M | $232M | $228M | $104M | $80M | $68M | $50M | $34M | $8M | $5M | |
| Retained Earnings | $-239M | $-201M | $-162M | $-130M | $-96M | $-71M | $-53M | $-40M | $-28M | $-17M | $-9M | $-6M | |
| Stockholders' Equity | $68M | $70M | $91M | $103M | $132M | $34M | $27M | $31M | $22M | $17M | $-635.2K | $-741.9K | |
| Liabilities + Equity | $131M | $117M | $104M | $114M | $142M | $44M | $37M | $31M | $24M | $22M | $741.5K | $2M | |
| Shares Outstanding | 18,067,744 | 7,247,243 | 6,354,371 | 146,211,130 | 145,979,429 | 55,576,996 | 28,930,493 | 16,198,791 | 8,345,844 | 4,875,871 | 34,117,886 | 30,025,295 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $12M | $7M | $4M | $1M | $803.3K | $716.0K | $779.7K | $986.6K | $732.2K | $732.2K | $470.2K | |
| Deferred Tax | $1M | $576.0K | $576.0K | $576.0K | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-27M | $-28M | $-29M | $-28M | $-24M | $-17M | $-12M | $-11M | $-8M | $-6M | $-2M | $-183.2K | |
| CapEx | · | · | · | · | $6.9K | $1.8K | · | · | $2.1K | · | · | · | |
| Investing Cash Flow | $-6M | $-5M | · | · | $-40M | $-1.8K | · | · | $-2.1K | $255.7K | · | · | |
| Stock Issued | $32M | $14M | · | · | $500 | · | · | · | · | · | · | $50.0K | |
| Net Stock Activity | · | · | · | · | $82.6K | · | · | · | · | · | · | · | |
| Financing Cash Flow | $33M | $10M | $14M | · | $120M | $23M | $11M | $17M | $11M | $5M | $2M | $2M | |
| Net Change in Cash | · | · | · | · | · | · | $-1M | $6M | $3M | $-381.8K | $-875.9K | $1M | |
| Free Cash Flow | · | · | · | · | $-24M | $-17M | · | · | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | -924229.7% | -105346.7% | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | -1029242.9% | -94659.8% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | -1029242.9% | -94659.8% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | -924229.7% | -105346.7% | · | |
| ROA | · | · | -29.9% | -26.2% | -24.8% | -43.6% | -51.8% | -45.2% | · | -73.1% | -252.5% | · | |
| ROE | · | · | -33.6% | -28.6% | -27.8% | -59.6% | -64.0% | -50.6% | · | -102.8% | 421.5% | · | |
| ROIC | · | · | -41.2% | -33.0% | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 5.9 | 9.8 | 18.3 | 3.4 | 1.7 | 3.2 | · | 0.2 | 0.5 | · | |
| Quick Ratio | · | · | 4.6 | 9.2 | 17.6 | 3.4 | 1.7 | 2.9 | · | 0.1 | 0.5 | · | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | · | -2171.0 | -1130.0 | -948.6 | -870.6 | · | -828.3 | -430.7 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $0.57 | $0.70 | $0.91 | $0.61 | $0.84 | $1.72 | · | $0.23 | $-0.02 | · | |
| Cash Flow / Share | · | · | $-0.19 | $-0.19 | · | · | · | · | · | · | · | · | |
| Cash / Share | · | · | $0.17 | $0.29 | $0.48 | $0.25 | $0.27 | $0.57 | · | $0.00 | $0.02 | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | $0.60 | · | · | |
| EPS (TTM) | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-40M | $-39M | $-33M | $-34M | $-23M | $-18M | $-16M | $-13M | $-10M | $-8M | $-3M | · | |
| Market Cap | · | · | $2.72B | $4.42B | $7.41B | $1.45B | $548M | $692M | · | $17.28B | $21.75B | · | |
| Enterprise Value | · | · | · | · | · | $1.43B | $541M | $683M | · | · | · | · | |
| P/E | -0.4 | -2.1 | -3.1 | -131.5 | -220.7 | · | · | · | · | · | · | · | |
| P/B | · | · | 29.9 | 43.0 | 56.0 | 42.9 | 22.5 | 24.9 | · | 1030.6 | -34240.7 | · | |
| P / Tangible Book | 0.4 | 1.5 | 33.3 | 47.3 | 60.3 | 59.4 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | -93.5 | -155.9 | -305.5 | -85.3 | -44.1 | -61.2 | · | -2928.4 | -9118.0 | · | |
| P / FCF | · | · | · | · | -305.4 | -85.3 | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | -80.8 | -34.7 | -49.6 | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -84.5 | · | · | · | · | · | · | |
| Earnings Yield | -272.6% | -47.7% | -32.6% | -0.76% | -0.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · |
Income Statement
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cost of Revenue | $491.8K | $328.9K | $789.2K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | $1M | $1M | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $1M | $2M | $2M | $2M | $2M | $4M | $2M | $3M | $3M | $4M | $3M | $3M | $4M | $5M | $3M | $4M | |
| SG&A Expense | $6M | $26M | $6M | $4M | $4M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | $3M | $3M | |
| Operating Expenses | $13M | $34M | $12M | $8M | $9M | $11M | $10M | $11M | $11M | $11M | $9M | $10M | $9M | $11M | $7M | $8M | |
| Operating Income | $-12M | $-32M | $-9M | $-8M | $-9M | $-11M | $-10M | $-11M | $-11M | $-11M | $-9M | $-10M | $-9M | $-11M | $-7M | $-8M | |
| Interest Expense | $198.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Income | $116.7K | $53.6K | $45.1K | $53.4K | $20.6K | $13.4K | $22.6K | $117.3K | $204.8K | $182.2K | $253.6K | $324.8K | $336.8K | $303.3K | $214.5K | $134.8K | |
| Other Non-op | $-294.5K | $4M | $-110.4K | $-42.1K | $-151.6K | $13.4K | $22.6K | $117.3K | $204.8K | $3M | $253.6K | $324.8K | $336.8K | $303.3K | $4M | · | |
| Pretax Income | $-12M | $-28M | $-9M | $-8M | $-9M | $-11M | $-10M | $-11M | $-10M | $-8M | $-9M | $-10M | $-8M | $-10M | $-3M | $-7M | |
| Income Tax | $-107.3K | $-231.2K | $264.2K | $264.2K | $264.2K | $264.2K | $264.2K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | · | |
| Net Income | $-12M | $-28M | $-9M | $-9M | $-9M | $-12M | $-10M | $-11M | $-11M | $-9M | $-9M | $-10M | $-8M | $-11M | $-4M | $-8M | |
| EPS (Basic) | $-0.34 | $-0.95 | $-0.38 | $-0.01 | $-0.80 | $-1.27 | $-1.30 | $-1.61 | $-1.57 | $-1.34 | $-1.45 | $-5.42 | $-0.06 | $-0.07 | $-0.02 | · | |
| EPS (Diluted) | $-0.34 | $-0.95 | $-0.38 | $-0.01 | $-0.80 | $-1.27 | $-1.30 | $-1.61 | $-1.57 | $-1.34 | $-1.45 | $-5.42 | $-0.06 | $-0.07 | $-0.02 | · | |
| Shares (Basic) | 26,169,589 | 22,376,427 | 21,495,274 | · | 11,006,896 | 8,581,207 | 7,492,460 | · | 6,954,278 | 6,362,890 | 6,358,237 | · | 153,775,380 | 146,251,945 | 146,211,130 | · | |
| Shares (Diluted) | 26,169,589 | 22,376,427 | 21,495,274 | · | 11,006,896 | 8,581,207 | 7,492,460 | · | 6,954,278 | 6,362,890 | 6,358,237 | · | 153,775,380 | 146,251,945 | 146,211,130 | · | |
| EBITDA | $-12M | $-32M | $-9M | · | $-9M | $-11M | $-10M | · | $-11M | $-11M | $-9M | · | $-9M | $-11M | $-7M | · |
Balance Sheet
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $5M | $8M | $4M | $6M | $26.4K | $1M | $3M | $18M | $13M | $20M | $26M | $33M | $29M | $37M | $42M | |
| Receivables | $686.2K | $1M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $23M | $23M | $23M | $22M | $17M | $15M | $14M | $8M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $1M | $1M | $3M | $3M | $3M | $10M | $9M | $8M | $8M | $8M | $6M | $5M | $3M | |
| Current Assets | $43M | $32M | $38M | $28M | $25M | $18M | $18M | $14M | $28M | $22M | $28M | $34M | $41M | $35M | $42M | $45M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $275 | $854 | $1.4K | $2.0K | $2.6K | $3.4K | $4.1K | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $98M | $100M | $102M | $102M | $102M | $102M | $102M | $102M | · | · | · | $69M | · | · | · | · | |
| Total Assets | $142M | $133M | $140M | $131M | $128M | $121M | $121M | $117M | $97M | $91M | $97M | $104M | $110M | $104M | $112M | $114M | |
| Accounts Payable | $8M | $9M | $11M | $14M | $10M | $9M | $7M | $5M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $1M | |
| Accrued Liabilities | $26M | $24M | $5M | $4M | $9M | $9M | $6M | $17.0K | $550.5K | $151.2K | $276.9K | $476.3K | $892.9K | $2M | $690.4K | $1M | |
| Short-term Debt | · | · | $1M | $1M | $1M | $300M | $300M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $52M | $55M | $38M | $45M | $52M | $50M | $45M | $36M | $4M | $4M | $6M | $6M | $6M | $6M | $5M | $5M | |
| Capital Leases | $590.8K | $636.7K | $681.6K | $724.9K | $767.0K | $786.7K | · | $21.3K | $84.4K | $145.1K | $204.6K | $262.9K | $320.0K | $374.8K | $428.6K | $481.2K | |
| Deferred Tax | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Total Liabilities | $66M | $63M | $47M | $53M | $60M | $58M | $52M | $43M | $11M | $11M | $12M | $12M | $12M | $12M | $11M | $11M | |
| Total Debt | · | · | $1M | · | $1M | $300M | $300M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $27.5K | $22.4K | $22.4K | $18.1K | $14.5K | $8.8K | $7.7K | $7.2K | $180.7K | $159.1K | $159.0K | $6.4K | $158.9K | $146.4K | $146.2K | $146.2K | |
| Paid-in Capital | $344M | $330M | $327M | $306M | $296M | $283M | $277M | $271M | $276M | $259M | $256M | $253M | $250M | $235M | $234M | $232M | |
| Retained Earnings | $-277M | $-268M | $-247M | $-239M | $-231M | $-222M | $-211M | $-201M | $-191M | $-180M | $-171M | $-162M | $-152M | $-144M | $-133M | $-130M | |
| Stockholders' Equity | $67M | $62M | $80M | $68M | $65M | $61M | $65M | $70M | $86M | $79M | $85M | $91M | $98M | $91M | $100M | $103M | |
| Liabilities + Equity | $142M | $133M | $140M | $131M | $128M | $121M | $121M | $117M | $97M | $91M | $97M | $104M | $110M | $104M | $112M | $114M | |
| Shares Outstanding | 27,452,570 | 22,376,427 | 22,376,427 | 18,067,744 | 14,475,029 | 8,760,649 | 7,727,243 | 7,247,243 | 180,725,407 | 159,094,781 | 158,966,576 | 6,354,371 | 158,857,798 | 146,357,797 | 146,211,130 | 146,211,130 |
Cash Flow
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $1M | $1M | $1M | $976.7K | |
| Deferred Tax | $-107.3K | $-231.2K | $264.2K | $264.2K | $264.2K | $264.2K | $264.2K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | $144.0K | · | |
| Operating Cash Flow | $-9M | $-1M | $-13M | $-12M | $-5M | $-5M | $-5M | $-6M | $-8M | $-8M | $-6M | $-7M | $-10M | $-8M | $-5M | $-6M | |
| Investing Cash Flow | $-2M | $-600.0K | $-4M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $4M | $-62.8K | $21M | $16M | $10M | $3M | $3M | $84.7K | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $21M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $23M | $-1M | $21M | $16M | $11M | $3M | $3M | $-4M | · | · | · | $-687 | $14M | · | · | · |
Profitability
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 80.3% | 80.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -785.4% | -1931.0% | -228.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -797.9% | -1686.0% | -238.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -805.1% | -1699.8% | -231.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -785.4% | -1931.0% | -228.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -8.8% | -22.1% | -7.2% | · | -8.2% | -10.8% | -9.4% | · | -10.2% | -8.8% | -8.8% | · | -7.3% | -9.1% | -2.9% | · | |
| ROE | -18.1% | -46.0% | -12.9% | · | -12.2% | -16.4% | -13.7% | · | -11.5% | -10.0% | -10.0% | · | -8.2% | -10.1% | -3.2% | · | |
| ROIC | -17.5% | -51.9% | -11.5% | · | -13.7% | -3.2% | -2.8% | · | -12.6% | -14.1% | -11.2% | · | -9.0% | -11.9% | -7.5% | · |
Liquidity & Solvency
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.6 | 1.0 | · | 0.5 | 0.4 | 0.4 | · | 6.7 | 5.2 | 5.1 | · | 7.1 | 5.6 | 9.3 | · | |
| Quick Ratio | 0.3 | 0.1 | 0.3 | · | 0.1 | 0.0 | 0.0 | · | 4.3 | 3.0 | 3.6 | · | 5.7 | 4.7 | 8.1 | · | |
| Debt / Equity | · | · | 0.0 | · | 0.0 | 4.9 | 4.6 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | -59.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Efficiency
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory Turnover | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.4 | 3.1 | 1.9 | · | · | · | · | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.43 | $2.75 | $3.57 | · | $4.49 | $6.92 | $8.46 | · | $0.47 | $0.50 | $0.53 | · | $0.61 | $0.62 | $0.69 | · | |
| Revenue / Share | $0.06 | $0.07 | $0.18 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | $-0.61 | · | · | · | $-0.63 | · | · | · | $-0.04 | · | · | · | $-0.03 | · | |
| Cash / Share | $0.62 | $0.21 | $0.35 | · | $0.42 | $0.00 | $0.14 | · | $0.10 | $0.08 | $0.13 | · | $0.21 | $0.20 | $0.25 | · | |
| EPS (TTM) | $-1.68 | $-2.14 | $-2.46 | · | $-4.98 | $-5.75 | $-5.82 | · | $-9.78 | $-8.27 | $-7.00 | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | |
| Net Income TTM | $-58M | $-55M | $-39M | · | $-42M | $-43M | $-40M | · | $-38M | $-36M | $-38M | · | $-31M | $-31M | $-28M | · | |
| Market Cap | $17M | $20M | $17M | · | $23M | $13M | $31M | · | $2.64B | $3.57B | $3.01B | · | $4.77B | $4.28B | $2.89B | · | |
| Enterprise Value | · | · | $11M | · | $18M | $313M | $330M | · | · | · | · | · | · | · | · | · | |
| P/E | -0.4 | -0.4 | -0.3 | · | -0.3 | -0.3 | -0.7 | · | -1.5 | -2.7 | -2.7 | · | · | · | · | · | |
| P/B | 0.2 | 0.3 | 0.2 | · | 0.4 | 0.2 | 0.5 | · | 30.8 | 45.0 | 35.5 | · | 48.8 | 46.9 | 28.8 | · | |
| P / Tangible Book | 0.3 | 0.4 | 0.2 | · | 0.4 | 0.3 | 0.6 | · | 34.6 | 51.0 | 39.9 | · | 53.9 | 52.3 | 31.7 | · | |
| P / Cash Flow | · | · | -1.3 | · | · | · | -6.5 | · | · | · | -490.3 | · | · | · | -598.6 | · | |
| Earnings Yield | -277.7% | -237.8% | -316.6% | · | -313.2% | -385.9% | -145.5% | · | -67.0% | -36.9% | -37.0% | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Net Income | $-40M | $-39M | $-33M | $-34M | $-23M |
| Diluted EPS | $-3.38 | $-5.97 | $-5.57 | $-0.23 | $-0.23 |
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Current Ratio | · | · | 5.9 | 9.8 | 18.3 |
| Quick Ratio | · | · | 4.6 | 9.2 | 17.6 |
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | · | · | $-24M |
Institutional owners (13F) 43 filers · $964K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
43
Value held
$964K
New positions
12
Exited positions
8
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 12 (+2 vs prior Q) | 8 (-1 vs prior Q) | 8 (+1 vs prior Q) | 9 (+2 vs prior Q) | +310K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $154,824 | 199,258 | 16.06% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $130,302 | 215,537 | 13.51% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $119,405 | 197,364 | 12.38% | Shares |
| Miller Financial Services LLC | $78,585 | 130,000 | 8.15% | Shares |
| CITADEL ADVISORS LLC | $75,508 | 124,910 | 7.83% | Shares |
| JANE STREET GROUP, LLC | $74,255 | 122,837 | 7.70% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $47,042 | 77,755 | 4.88% | Shares |
| BlackRock, Inc. | $42,224 | 69,850 | 4.38% | Shares |
| NORTHERN TRUST CORP | $37,928 | 62,742 | 3.93% | Shares |
| XTX Topco Ltd | $35,786 | 59,199 | 3.71% | Shares |
| Asset Advisory Group, Inc. | $35,672 | 59,011 | 3.70% | Shares |
| BostonPremier Wealth LLC | $16,926 | 28,000 | 1.76% | Shares |
| UBS Group AG | $15,933 | 26,335 | 1.65% | Shares |
| LPL Financial LLC | $15,381 | 25,445 | 1.60% | Shares |
| STATE STREET CORP | $14,067 | 23,271 | 1.46% | Shares |
| Arkadios Wealth Advisors | $12,090 | 20,000 | 1.25% | Shares |
| TWO SIGMA INVESTMENTS, LP | $10,575 | 17,494 | 1.10% | Shares |
| Sanctuary Advisors, LLC | $7,139 | 11,810 | 0.74% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7,130 | 11,795 | 0.74% | Shares |
| R Squared Ltd | $6,670 | 11,033 | 0.69% | Shares |
| TWO SIGMA SECURITIES, LLC | $6,049 | 10,006 | 0.63% | Shares |
| SBI Securities Co., Ltd. | $5,754 | 9,519 | 0.60% | Shares |
| CHELSEA COUNSEL CO | $2,797 | 4,626 | 0.29% | Shares |
| Quent Capital, LLC | $2,558 | 4,232 | 0.27% | Shares |
| IFP Advisors, Inc | $2,529 | 4,183 | 0.26% | Shares |
| Tower Research Capital LLC (TRC) | $1,647 | 2,724 | 0.17% | Shares |
| OSAIC HOLDINGS, INC. | $1,543 | 2,575 | 0.16% | Shares |
| GROUP ONE TRADING LLC | $938 | 1,551 | 0.10% | Shares |
| SIMPLEX TRADING, LLC | $759 | 1,256 | 0.08% | Shares |
| BARCLAYS PLC | $663 | 1,096 | 0.07% | Shares |
| WELLS FARGO & COMPANY/MN | $605 | 1,000 | 0.06% | Shares |
| Luminist Capital LLC | $263 | 435 | 0.03% | Shares |
| ASSETMARK, INC | $225 | 372 | 0.02% | Shares |
| Princeton Global Asset Management LLC | $97 | 160 | 0.01% | Shares |
| Smallwood Wealth Investment Management, LLC | $72 | 120 | 0.01% | Shares |
| JPMORGAN CHASE & CO | $69 | 120 | 0.01% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $65 | 107 | 0.01% | Shares |
| Arax Advisory Partners | $51 | 84 | 0.01% | Shares |
| Federation des caisses Desjardins du Quebec | $48 | 80 | 0.00% | Shares |
| MORGAN STANLEY | $27 | 44 | 0.00% | Shares |
| Fairscale Capital, LLC | $25 | 42 | 0.00% | Shares |
| Virtu Financial LLC | $13 | 20,836 | 0.00% | Shares |
| Bogart Wealth, LLC | $2 | 4 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Leonard L. Mazur ×3 filings | Nov. 27, 2024 | · | Initial filing | · | SEC |
| Myron Z. Holubiak ×2 filings | Feb. 18, 2022 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 11 insiders · 4 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Leonard L Mazur | Chief Executive Officer | Aug. 8, 2025 A | 10,255,343 | 0 | 0 | $0 |
| Jaime Bartushak | Chief Financial Officer | Nov. 7, 2024 A | · | 0 | 0 | $0 |
| Myron Z Holubiak | Vice Chairman | Aug. 8, 2025 A | 1,992,243 | 0 | 0 | $0 |
| Myron Czuczman | Chief Medical Officer | Nov. 7, 2024 A | · | 0 | 0 | $0 |
| Robert Joseph Smith | Director | Nov. 7, 2024 A | · | 0 | 0 | $0 |
| Eugene Myron Holuka | Director | Nov. 7, 2024 A | 2,367 | 0 | 0 | $0 |
| Carol Webb | Director | Nov. 7, 2024 A | 11,835 | 0 | 0 | $0 |
| Suren G Dutia | Director | Nov. 7, 2024 A | · | 0 | 0 | $0 |
| Dennis M Mcgrath | Director | Nov. 7, 2024 A | · | 0 | 0 | $0 |
| William Kane | Director | Oct. 4, 2022 A | · | 0 | 0 | $0 |
| Howard Safir | Director | Oct. 4, 2022 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 197,364 SH | Aug. 19, 2026 | Daily |
CTXR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$4.00
+652.4%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-02Mean target $4.00 +652.4%
Low$4.00
Mean$4.00
High$4.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CTXR | · | -0.4 | · | · | · | · |
| RKTO | · | · | · | · | · | · |
| LPCN | $49M | -4.8 | -82.3% | -487.1% | -60.9% | · |
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | · |
| TVRD | $40M | -1.3 | -66.0% | · | -67.6% | · |
| BFRI | · | · | · | · | · | · |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| CALC | · | -3.3 | -29.7% | · | · | · |
| KPRX | $7M | -0.7 | · | · | -56.6% | · |
| ADIL | $244.4K | -0.0 | · | · | -146.8% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026